This report from Life Science Intelligence provides an analysis of the global market for diagnostic electrophysiology catheters. These devices are used to measure and map electrical activity within the heart to identify aberrant electrical activity that causes arrhythmias. LSI projects that this market will remain in a growth phase due to improving technology for the treatment of atrial fibrillation (AFib). Device-based treatments are seeing increasing adoption for arrhythmia as an alternative to life-long pharmaceutical therapy.
This market snapshot is intended to provide a high-level overview of the global diagnostic electrophysiology catheters market, with key insights into:
Johnson & Johnson